AI accelerates drug development, cutting costs and boosting success rates. Discover how AI is reshaping the future of ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

The foundation of patient-focused drug development (PFDD) is to involve patients in the entire drug development process, from clinical trial design to post-market surveillance. While traditional ...

EXPLORE Health Money Travel Food Style Book Club Classifieds #ZoomerDaily Policy & Perspective Arts & Entertainment Stars & ...

Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

The pharmaceutical industry is at a pivotal moment. Artificial intelligence (AI) is shifting from improving processes to reshaping disease treatment and care delivery. Early adopters are seeing ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...